The results evidenced the presence of ocular anti-SARS-CoV-2 IgA in 10/28 (35.7%) of the enrolled COVID-19 patients, with variable concentrations, ranging from R = 0.896 ± 0.01 (weakly positive) to R = 9.822 ± 0.13 (strongly positive) (Figure 1). Here, CD79A is linked to COVID-19.